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     BSTRACT
Contagious respiratory infections are an important cause of respiratory disease in horses, 
resulting in impaired pulmonary function, poor performance and sometimes severe illness. Al-
though bacterial infections are often suspected to be involved, viruses are frequently overlooked 
and are an underestimated cause of respiratory disease outbreaks in horses. In this study, nasal 
swabs of 103 horses with acute symptoms of respiratory disease were analyzed for the presence 
of 13 different respiratory pathogens. Gamma herpesviruses were the most commonly detected, 
with 60% of the samples being positive, followed by streptococcus equi subsp. zooepidemicus in-
fection (30%). Rhinovirus B, streptococcus equi subsp. equi, adenovirus 1 and EHV-4 were more 
rarely detected. Further research is necessary to correctly interpret the importance of gamma 
herpesviruses in horses, for example by screening a healthy control population.  National surveil-
lance of respiratory viruses in horses by PCR analysis on nasal swabs might be a useful, early-
warning system for viral epidemics.
SAMENVATTING
Infectieuze aandoeningen zijn een belangrijke oorzaak van ademhalingsproblemen bij paarden. 
Ze kunnen aanleiding geven tot een verstoorde longfunctie, verminderde prestaties en soms ernstige 
klinische ziekte. Hoewel meestal bacteriële infecties vermoed worden, zijn virussen een onderschatte 
oorzaak van besmettelijke ademhalingsinfecties bij paarden. In deze studie werden neusswabs genomen 
bij 103 paarden met symptomen van acute ademhalingsinfectie en gescreend op de aanwezigheid van 
13 verschillende equine ademhalingspathogenen. Gammaherpesvirussen waren, met 60% positieve 
stalen, de meest gedetecteerde pathogenen, gevolgd door streptococcus equi subsp. zooepidemicus 
infecties (30%). Rhinovirus B, streptococcus equi subsp. equi, adenovirus 1 en EHV-4 werden minder 
frequent gevonden. Verder onderzoek is nodig om het belang van gammaherpesvirussen bij het paard 
correct te interpreteren. Nationale surveillance van ademhalingsvirussen bij paarden door middel van 
PCR-analyse op neusswabs zou een nuttig waarschuwingssysteem voor dreigende virale epidemieën 
kunnen zijn.  
A
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INTRODUCTION
Respiratory problems are among the most impor-
tant disorders limiting the athletic performance of the 
horse. Consequently, early detection and adequate 
treatment are essential to maximize the chances of 
recovery and to reduce economic and performance 
losses  (Van Erck-Westergren et al., 2013). Infectious 
diseases are frequently involved in clinical or sub-
clinical respiratory disorders. Field studies on viral 
antigens in the respiratory tract are limited in horses, 
and hence, the prevalence of respiratory pathogens 
is unknown in many countries, including Belgium. 
Identification of etiologic agents requires labora-
tory analysis on samples from the respiratory tract. 
Whereas sampling of the lower airways is not always 
straightforward in first-line clinical practice, the use 
of nasal swabs offers a more achievable alternative, 
especially for viruses, as recently documented in a na-
tional surveillance program for respiratory viruses in 
cattle in Ireland (O'Neill et al., 2014). The objective of 
the present survey was to determine the nasal preva-
lence of infectious respiratory agents in horses with 
acute respiratory disease in Belgium.
MATERIALS AND METHODS
Belgian equine veterinarians were requested to 
sample horses showing clinical signs suggestive of 
an acute respiratory disease. Inclusion criteria for the 
study were acute (<3 days) onset of fever (rectal tem-
perature  >38.5°C) and at least one of the following 
other criteria: nasal discharge, cough, lymphadenopa-
thy or an obvious contagious character of the occur-
ring disease (> two horses affected). No more than 
two horses within the same premises were sampled. 
Dry nasal cotton swabs were advanced deep (>30cm) 
into the ventral nasal conchae. The swabs were 
placed in a viral transport medium and kept cooled at 
8°C during transport and prior to analysis. Samples 
were analyzed for 13 different respiratory pathogens 
(equine influenza virus (EIV), equine herpesvirus 
(EHV) 1, 2, 4 and 5, equine arteritis virus (EAV), ad-
enovirus 1 and 2, coronavirus, equine rhinitis virus 
A (ERAV) and B (ERBV), Streptococcus equi subsp. 
zooepidemicus and Streptococcus equi subsp. equi). 
Briefly, nucleic acid was extracted from 140µL of 
fluids with the QIAamp RNA minikit (Qiagen, Les 
Ulis, France) according to the manufacturer’s instruc-
tions. The final elution was 50µL. The different PCRs 
were performed after development and validation as 
described previously (Hue et al., 2014). All the qPCRs 
used were characterized (limit of detection method, 
limit of quantification method, limit of detection PCR 
limit of quantification PCR) and validated for the use 
in horses according to the French AFNORnorm U47-
600 and as described for EHV2 by Hue et al. (2015). 
RESULTS
Between January and September 2014, a total of 
103 horses in 95 suspected outbreaks of acute conta-
gious respiratory disease were sampled. Other clini-
cal signs in addition to fever, were nasal discharge 
(60/103, 58%), cough (33/103, 32%) and lymphade-
nopathy (24/103, 23%). An overview of the PCR re-
sults is shown in Table 1. In 71% of cases, a positive 
result was obtained. EHV2 and EHV5 were the most 
commonly detected pathogens with 60% of the horses 
positive for EHV2, EHV5 or both (62/103). Mixed 
infections were present in 45% of the horses (46/103), 
mostly involving EHV2 and EHV5.  
DISCUSSION
The objective of the present study was to deter-
mine the prevalence of infectious respiratory agents in 
horses with acute respiratory disease in Belgium. This 
type of prevalence studies is biased by the fact that a 
random sampling is difficult to perform in practice. 
Furthermore, samples were taken by first-line practi-
tioners, so protocol compliance is difficult to evalu-
ate. Incorrect sample collection and transport may 
lead to false negative results. Therefore, the results on 
the convenience sample of the present study should 
be interpreted as indicative but not representative 
for the whole Belgian equine population. The use of 
PCR on nasal swabs provided an accessible diagnos-
tic procedure for first-opinion practice. The envisaged 
amount of samples was obtained within a reasonable 
timeframe, which is an essential prerequisite for any 
surveillance program for respiratory pathogens. 
The present study provided interesting results on 
the relative importance of respiratory viruses and bac-
teria affecting the upper airways in horses. The most 
important observation was the abundant presence of 
equine gamma herpesviruses (EHV2 and EHV5). Se-
rological studies demonstrated that EHV2 is endemic 
in equine populations worldwide, with approximately 
90% of horses being seropositive, but the nasal pres-
ence of viral DNA in healthy as well as in diseased 
horses is scarcely documented (Nordengrahn et al., 
2002). Because of the high number of seropositive 
horses and the lack of serological differences between 
healthy and diseased horses, opinions vary as to the 
true pathogenicity of EHV2. Since EHV2 is frequently 
detected in combination with other respiratory patho-
gens, which was confirmed in the present study, the 
suggestion has been made that EHV2 can predispose 
horses to other viral and bacterial infections (Nor-
dengrahn et al., 1996). However, EHV2 was the sole 
pathogen found in nine horses in the present study, 
which might suggest primary pathogenicity of EHV2. 
For EHV5, seroprevalence studies show conflict-
ing results (Akkutay et al., 2014; Nordengrahn et al., 
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2002). In the present study, EHV5 was detected in 
almost half of the horses showing acute respiratory 
signs and often in combination with EHV2 or other 
pathogens. However, EHV5 was the sole pathogen 
in 11 of the included horses. EHV5 has been isolated 
from healthy horses as well as from horses with a va-
riety of respiratory diseases, making its clinical im-
portance difficult to interpret (Dunowska et al., 1999; 
Nordengrahn et al., 2002). Recently, EHV5 has often 
been mentioned in relation to equine multinodular 
pulmonary disease. None of the horses of the present 
study developed lesions compatible with this condi-
tion. A second interesting finding was the absence of 
EIV in the studied population. Possible explanations 
might be the widespread vaccination against EIV in 
Belgium and the narrow timeframe for virus detec-
tion, namely 24 hours after the onset of clinical signs 
(Gilkerson et al., 2015; Kirkland et al., 2011). For re-
spiratory bacteria, the frequent presence of Strepto-
cuccus equi subsp. zooepidemicus (30%) is difficult 
to interpret, since this opportunistic pathogen can be a 
normal inhabitant of the upper airways (Lindahl et al., 
2013). However, the presence of Streptococcus equi 
subsp. equi is always significant and warrants imme-
diate action to prevent spread to other horses.
Next to the difficulties of random sampling, another 
important limitation of this study was the lack of a 
control group for prevalence determination in healthy 
horses. More studies and serological surveys would be 
very useful to compare prevalences of this subset of 
respiratory pathogens in healthy versus ill horses, in 
order to gain more insight into the true pathogenicity 
of these agents.
CONCLUSION
The present study indicates that equine gamma 
herpesviruses are most frequently detected in nasal 
samples of horses with acute respiratory disease in 
Belgium. As recommended for bovine respiratory dis-
eases in Belgium and already applied in France and 
the UK for equine respiratory infections (Legrand et 
al., 2013; O'Neill et al., 2014; Pardon, 2014; Pardon 
et al., 2011), national surveillance of respiratory vi-
ruses in horses by PCR analysis on nasal swabs might 
Table 1. Respiratory pathogens detected by PCR performed on nasal swabs of 103 horses with acute respiratory dis-
ease in Belgium (2014). Data are shown both on herd level (95 different herds) as on horse level (103 individual horses). 
Pathogen Single Infections Mixed Infections Total
Negative / / 29%
 / / (30/103)
  
EIV 0% 0% 0% 
 (0/103) (0/103) (0/103)
EHV1 0% 1% 1% 
 (0/103) (1/103) (1/103)
EHV4 1% 6% 7% 
 (1/103) (6/103) (7/103)
EHV2 9% 39% 48% 
 (9/103) (40/103) (49/103)
EHV5 11% 43% 53% 
 (11/103) (44/103) (55/103)
EAV 0% 0% 0% 
 (0/103) (0/103) (0/103)
Adenovirus 1 0% 4% 4% 
 (0/103) (4/103) (4/103)
Adenovirus 2 0% 0% 0% 
 (0/103) (0/103) (0/103)
Coronavirus 0% 0% 0% 
 (0/103) (0/103) (0/103)
ERBV 2% 13% 15% 
 (2/103) (13/103) (15/103)
ERAV 0% 0% 0% 
 (0/103) (0/103) (0/103)
S. equi subsp. zooepidemicus 4% 26% 30% 
 (4/103) (27/103) (31/103)
S. equi subsp. equi 0% 13% 13% 
 (0/103) (13/103) (13/95)
EIV: equine influenza virus; EHV: equine herpesvirus; EAV: equine arteritis virus; ERBV: equine rhinitis virus B; ERAV: 
equine rhinitis virus A
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be a useful, early-warning system for viral epidem-
ics. However, more large scale surveillance studies 
are needed both in healthy and sick horses, to evalu-
ate the value of nasal swab PCR analysis results in a 
population of horses for early detection of threatening 
epidemics. Most probably, longitudinal studies with 
follow-up in time will be needed for this purpose.
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